Opening Recap
Market Pulse → After last week’s slaughter, Bitcoin clawed back as Coinbase premiums turned higher, rattling crypto bears and lifting sentiment across risk assets.
Key Movers → Bitcoin’s relief rally, Rockwell Automation’s post-earnings slide despite a beat, and the Netflix-Warner merger debates drove chatter of buy-the-dip setups and regulatory roadblocks.
Macro & Politics → Theater owners’ antitrust warnings spotlight growing political scrutiny on mega-deals, while FDA eyes Roche’s fenebrutinib as a major biotech catalyst.
What’s Next → Watch Fed speakers today for hints on inflation tolerance and crypto-derivative volumes for signs of a genuine short squeeze.
Market Commentary
Everyone’s ignoring that Roche’s fenebrutinib data isn’t just another pipeline booster – if the FDA drags its feet or imposes unexpected conditions, biotech stocks could be left holding the bag. GlobeNewswire’s report on the primary progressive MS trial success got buried under the Netflix-Warner noise, but missing that spark could cost you.
The same hand-wringing that fueled shorts around Bitcoin’s bounce also torched software names in the AI frenzy – SiliconANGLE News’s story on AI torching SaaS runs parallel to the regulators gunning for Netflix. Both show how hype and policy can collide and leave retail investors scrambling.
Action time: If you’re long Roche or any pre-approval biotech, trim exposure or tie your position to FDA outcomes. Hedge software bets until the AI sell-off stabilizes. And for crypto players chasing squeezes, set stop losses – luck favors the prepared.
📈 Breaking Financial News
Cinema United, formerly the National Association of Theater Owners, has warned of a coming collapse if the Netflix-WB merger deal finalizes.
Rockwell Automation is well-positioned to automate total returns, with a bullish stock price outlook, share buybacks, dividends, and distribution growth.
This could lead to less FDA oversight just when more is needed.
Analysts maintain a cautious stance even after Bitcoin’s 12% relief rally clawed back recent losses amid a surging Coinbase Premium.
Liquidations around $0.6 have been swept, but a denser band of liquidity may be clustered around $0.734.
Did you spot this in the Oval Office last week?
When Tim Cook stood in the Oval Office last week, all eyes were on the “unique 24K gold gift” he presented to President Trump. But many viewers missed an even more important moment in that 30-second clip. One that unmistakably singled out what Futurist Eric Fry calls “possibly the best AI investment anyone could make right now.” Click to get full details on the company.
🔍 Market Analysis & Insights
A popular dietary supplement has been recalled due to its link to a dangerous, multi-state salmonella outbreak. Why Not Natural voluntarily recalled its Pure Organic Moringa Green Superfood capsules. The outbreak is significant and growing, with at least 65 i…
Basel, 07 February 2026 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new late-breaking data from the Phase III FENtrepid study showing the investigational Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib met its primary endpoint of non-inferiorit…
Billionaires like Bezos and Trump have no real interest in a free press — particularly when massive profits are on the line.
Emmeline Clein
The medspa industry is moving more quickly than we can keep up with. Meanwhile, women are being told that if we don’t too, we will lose our cosmetic capital.
Rockwell Automation (NYSE:ROK) reported fiscal first-quarter 2026 results that management said exceeded expectations on sales, margin, and earnings…
The Elon Musk “Mystery Metal” That Could Break China's Grip
Quietly engineered by Elon Musk… could end that crisis forever. And one tiny company is sitting at the center of it all. Musk is expected to make an announcement any day now. See more about this secret project here.
💰 Investment Opportunities
The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much
Novo Nordisk vowed to take legal action against telehealth company Hims & Hers for selling a knockoff of its weight loss pill.
Sarandos defended Netflix's Warner Bros. merger and argued customers hold the real power.
Investors think AI is going to kill or at least maim software-as-a-service companies, and a lot more. That seems a tad early, frankly, even if AI could slow SaaS’ growth story — which is why the likes of ServiceNow, Salesforce and even Palantir have seen thei…
Bitcoin price plunged to $60,000, its biggest single-day fall since the FTX crash. Prices rose to above $66,000 as analysts forecast a potential dead cat bounce. Market sentiment remains in extreme fear. Bitcoin fell sharply on Friday, crashing to lows of $60…
The Comeback of the Century: Wall Street Wrote Him Off…
But Elon's $3 Trillion Comeback Could Begin Soon. Elon Musk was declared washed up and finished. But any day now, he could unveil a new technology that outshines Tesla, SpaceX, even PayPal… a breakthrough big enough to solve America's toughest problem, make President Trump a hero to the Western World… and spark a $3 trillion boom. Early investors could see massive gains. Details here.